Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate

British Journal of Pharmacology

Volumn 131, Issue 5, 2000, Pages 1019-1023

  Kaesemeyer, Wayne H ^a   Ogonowski, Alison A ^a   Jin, Liming ^a   Caldwell, Ruth B ^a   Caldwell, Robert W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endothelial nitric oxide synthase; Glyceryl trinitrate (nitroglycerin); L arginine; Nitrate tolerance; Superoxide anion

Indexed keywords

ARGININE; GLYCERYL TRINITRATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033708990     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703665     Document Type: Article

References (27)

1. Role of L-arginine in the vascular actions development of tolerance to nitroglycerin
2. Tyrosine nitration in blood vessels occurs with increasing nitric oxide concentration
3. Angiostatic role of astrocytes: Suppression of vascular endothelial cell growth by TGF-β and other inhibitory factor(s)
4. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris
5. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance
6. On the mechanism of NO release from sydnonimines
7. Bradykinin induces superoxide anion release from human endothelial cells
8. The reaction of NO with superoxide
9. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle
10. Biology of disease: Cell and tissue responses to oxidative damage
11. Nitrates supplemented with L-arginine for the reversal and treatment of nitrate tolerance; two case reports
12. Differential induction of constitutive and inducible nitric oxide synthases by distinct inflammatory stimuli in bovine aortic endothelial cells
13. Superoxide anion is an endothelium-derived contracting factor
14. Agonist-induced peroxynitrite production from endothelial cells
15. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide
16. Angiotensin II receptor antagonism does not prevent tolerance to continuous transdermal nitroglycerin
17. Nitric oxide (NO) donor molecules: Effect of NO release rate on vascular smooth muscle cell proliferation in vitro
18. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability
19. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance
20. Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production
21. Nitrate therapy for stable angina pectoris
22. Substrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activity
23. Naive low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion
24. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells
25. Scavenging of hydroxyl radicals but not of peroxynitrite by inhibitors and substrates of nitric oxide synthases
26. Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture
27. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: A direct correlation between nitric oxide formation and protection